PAX2 and carcinoma: Similarly in breast cancer, expression of PAX2 has been associated with a low invasive phenotype in luminal breast cancer cells [54], while in endometrial cancer joint loss of PAX2 and PTEN expression was associated with progression to carcinoma [55].